166 related articles for article (PubMed ID: 22642023)
1. [COPD patients with heart failure: no concern about the beta blocker!].
Stiefelhagen P
MMW Fortschr Med; 2012 Apr; 154(6):26. PubMed ID: 22642023
[No Abstract] [Full Text] [Related]
2. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
3. Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease.
Su VY; Chang YS; Hu YW; Hung MH; Ou SM; Lee FY; Chou KT; Yang KY; Perng DW; Chen TJ; Liu CJ
Medicine (Baltimore); 2016 Feb; 95(5):e2427. PubMed ID: 26844454
[TBL] [Abstract][Full Text] [Related]
4. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
[TBL] [Abstract][Full Text] [Related]
5. Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study.
Sessa M; Mascolo A; Rasmussen DB; Kragholm K; Jensen MT; Sportiello L; Rafaniello C; Tari GM; Pagliaro C; Andersen M; Rossi F; Capuano A
Sci Rep; 2019 Aug; 9(1):11465. PubMed ID: 31391573
[TBL] [Abstract][Full Text] [Related]
6. Do pharmacological differences among beta-blockers affect their clinical efficacy in heart failure?
Di Lenarda A; Sabbadini G; Sinagra G
Cardiovasc Drugs Ther; 2004 Mar; 18(2):91-3. PubMed ID: 15293370
[No Abstract] [Full Text] [Related]
7. Therapeutic update: non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
Sirak TE; Jelic S; Le Jemtel TH
J Am Coll Cardiol; 2004 Aug; 44(3):497-502. PubMed ID: 15358010
[TBL] [Abstract][Full Text] [Related]
8. The evaluation of β-adrenoceptor blocking agents in patients with COPD and congestive heart failure: a nationwide study.
Liao KM; Lin TY; Huang YB; Kuo CC; Chen CY
Int J Chron Obstruct Pulmon Dis; 2017; 12():2573-2581. PubMed ID: 28894360
[TBL] [Abstract][Full Text] [Related]
9. Beta-blockers in congestive heart failure: the pharmacology of carvedilol, a vasodilating beta-blocker and antioxidant, and its therapeutic utility in congestive heart failure.
Feuerstein G; Ruffolo RR
Adv Pharmacol; 1998; 42():611-5. PubMed ID: 9327976
[No Abstract] [Full Text] [Related]
10. beta-adrenergic receptor blockade in chronic heart failure.
Bristow MR
Circulation; 2000 Feb; 101(5):558-69. PubMed ID: 10662755
[No Abstract] [Full Text] [Related]
11. Which beta-blocker for heart failure?
Patel MR; Gattis W
Am Heart J; 2004 Feb; 147(2):238. PubMed ID: 14760319
[No Abstract] [Full Text] [Related]
12. Meta-analysis of effect of beta-blocker therapy on mortality in patients with New York Heart Association class IV chronic congestive heart failure.
Whorlow SL; Krum H
Am J Cardiol; 2000 Oct; 86(8):886-9. PubMed ID: 11024409
[No Abstract] [Full Text] [Related]
13. Unique effects of carvedilol on noradrenaline release in the human heart.
Richardt G; Richardt D; Adler S; Kraatz E; Nötzold A; Kurz T
Eur J Heart Fail; 2002 Mar; 4(2):147-9. PubMed ID: 11959042
[No Abstract] [Full Text] [Related]
14. Current research on carvedilol in heart failure.
Bobadilla RV
Crit Care Nurse; 2002 Aug; 22(4):14, 16. PubMed ID: 12166050
[No Abstract] [Full Text] [Related]
15. In heart failure, all beta-blockers are not necessarily equal.
Tang WH; Militello M; Francis GS
Cleve Clin J Med; 2003 Dec; 70(12):1081-7. PubMed ID: 14686687
[TBL] [Abstract][Full Text] [Related]
16. [Beta blockers for therapy of chronic heart failure].
Murakami T
Nihon Naika Gakkai Zasshi; 2005 Feb; 94(2):248-54. PubMed ID: 15768588
[No Abstract] [Full Text] [Related]
17. Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial.
Lainscak M; Podbregar M; Kovacic D; Rozman J; von Haehling S
Respir Med; 2011 Oct; 105 Suppl 1():S44-9. PubMed ID: 22015086
[TBL] [Abstract][Full Text] [Related]
18. Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection.
Chin BS; Gibbs CR; Blann AD; Lip GY
Clin Sci (Lond); 2003 Oct; 105(4):507-12. PubMed ID: 12841846
[TBL] [Abstract][Full Text] [Related]
19. Major beta blocker mortality trials in chronic heart failure: a critical review.
McMurray JJ
Heart; 1999 Dec; 82 Suppl 4(Suppl 4):IV14-22. PubMed ID: 10574906
[No Abstract] [Full Text] [Related]
20. Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trial.
Hawkins NM; MacDonald MR; Petrie MC; Chalmers GW; Carter R; Dunn FG; McMurray JJ
Eur J Heart Fail; 2009 Jul; 11(7):684-90. PubMed ID: 19460848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
